The urinary methylation levels of FAM19A4, GHSR, MAL, miR-129, miR-935, PHACTR3, PRDM14, SST and ZIC1 were significantly higher in patients with bladder cancer than in controls (all, p < 0.001) (Fig. 2). Here, PRDM14 is linked to urinary bladder cancer.